SCHEME 1
Diastereoselective Synthesis of Carbapenams via
Kinugasa Reaction
Sebastian Stecko, Adam Mames, Bartłomiej Furman, and
Marek Chmielewski*
Institute of Organic Chemistry of Polish Academy of
Sciences Kasprzaka 44/52, 01-224 Warsaw, Poland
rangement of the intermediate isoxazoline.5 Later on, Miura and
co-workers developed a first catalytic version of this reaction
with a substoichiometric amount of CuI.6 The same authors
reported also a first asymmetric version of the Kinugasa reaction
using chiral bisoxazoline ligands.6 In following years, the
extended asymmetric versions of the Kinugasa reaction have
been proposed by groups of Basak,7 Fu,8 Tang,9and Guiry.10
In previous attempts, mostly the acyclic nitrones have been
tested.5-10 Only a limited number of examples of the use of
cyclic 1,3-dipole have been reported to date. These tend to offer,
however, a poor yield of the bicyclic ꢀ-lactams.5 In connection
with our interest in the synthesis of ꢀ-lactams,11 as well as in
the 1,3-dipolar cycloadditions involving cyclic nitrones,12 we
decided to investigate, for the first time, a general and a highly
stereoselective approach to the construction of the carbapenams
basic skeleton, using Cu(I)-mediated cycloaddition of nonra-
cemic nitrones and simple acetylenes (Scheme 1).
ReceiVed June 5, 2008
A facile approach to carbapenams via Kinugasa reaction
between terminal copper acetylides and nonracemic cyclic
nitrones derived from malic and tartaric acid is reported. The
stereochemical preferences observed in these reactions are
explained. The reaction provides an entry to the carbapenams
basic skeleton.
In this Note, we report our preliminary studies on the
Kinugasa reaction involving cyclic nitrones 1-3 and simple,
terminal acetylenes 4a-f. Both nitrones 1 and 2 are readily
available from S-malic acid,13 whereas nitrone 3 is derived from
L-tartaric acid.13
The ꢀ-lactam antibiotics represent the most powerful tool
against the bacterial infections. Owing to their attractive
biological activity, the synthesis and properties of mono- and
polycyclic systems containing the ꢀ-lactam ring have been
extensively investigated.1 The history of ꢀ-lactams goes back
to 1907 when Staudinger discovered the imine-ketene cycload-
dition.2 To date, a number of methodologies for the ꢀ-lactam
ring construction in both diastereoselective and enantioselective
manner have been developed.3 Some of these methods have
also found application in syntheses of the non-ꢀ-lactam com-
pounds.3
In 1972 Kinugasa and Hashimoto reported a convergent route
to ꢀ-lactams through the reaction between copper phenyl
acetylides and nitrones.4 Four years later, Ding and Irwin
proposed the mechanism of the Kinugasa reaction, which
involved the 1,3-dipolar cycloaddition and subsequent rear-
(5) Ding, L. K.; Irwin, W. J. J. Chem. Soc., Perkin Trans.1 1976, 2382.
(6) (a) Okuro, K.; Enna, M.; Miura, M.; Nomura, M. J. Chem. Soc., Chem.
Commun. 1993, 1107. (b) Miura, M.; Enna, M.; Okuro, K.; Nomura, M. J. Org.
Chem. 1995, 60, 4999.
(7) (a) Basak, A.; Mahato, T.; Bhattacharya, G.; Mukherje, B. Tetrahedron
Lett. 1997, 38, 643. (b) Basak, A.; Bahattacharya, G.; Bdour, H. M. Tetrahedron
1998, 54, 6529. (c) Basak, A.; Gosh, S. C.; Bhowmick, T.; Das, A. K.; Bertolasi,
V. Tetrahedron Lett. 2002, 43, 5499. (d) Basak, A.; Chandra, K.; Pal, R.; Ghosh,
S. C. Synlett 2007, 10, 1585. (e) Pal, R.; Ghosh, S.; Chandra, K.; Basak, A.
Synlett 2007, 15, 2321. (f) Ghosh, S.; Basak, A. Synlett 2004, 9, 1637.
(8) (a) Lo, M.; Fu, G. C. J. Am. Chem. Soc. 2002, 124, 4572. (b) Shintani,
R.; Fu, G. C. Angew. Chem., Int. Ed. 2003, 42, 4082.
(9) (a) Ye, M.-C.; Zhou, J.; Huang, Z.-Z.; Tang, Y. Chem. Commun. 2003,
2554. (b) Ye, M.-C.; Zhou, J.; Tang, Y. J. Org. Chem. 2006, 71, 3576.
(10) Coyne, A.; Mu¨ller-Bunz, H.; Guiry, P. J. Tetrahedron: Asymmetry 2007,
18, 199.
(11) (a) Chmielewski, M.; Kałuz˙a, Z.; Furman, B. J. Chem. Soc., Chem.
Commun. 1996, 2689. (b) Furman, B.; Borsuk, K.; Kałuz˙a, Z.; Łysek, R.;
Chmielewski, M. Curr. Org. Chem. 2004, 8, 463. (c) Łysek, R.; Borsuk, K.;
Furman, B.; Kałuz˙a, Z.; Kazimierski, A.; Chmielewski, M. Curr. Med. Chem.
2004, 11, 1813. (d) Cierpucha, M.; Panfil, I.; Danh, T. T.; Chmielewski, M.;
Kurztkowski, W.; Rajnisz, A.; Solecka, J. J. Antibiot. 2007, 60, 622. (e)
Furman,B.; Kałuz˙a, Z.; Stencel, A.; Grzeszczyk, B.; Chmielewski, M. In Topics
in Heterocyclic Chemistry; El Ashry, S., Ed.; Springer-Verlag: New York, 2007;
Vol. 7, p 101.
(12) (a) Jurczak, M.; Rabiczko, J.; Socha, D.; Chmielewski, M.; Cardona,
F.; Goti, A.; Brandi, A. Tetrahedron: Asymmetry 2000, 11, 2015. (b) Socha, D.;
Jurczak, M.; Frelek, J.; Klimek, A.; Rabiczko, J.; Urban´czyk-Lipkowska, Z.;
Suwin´ska, K.; Chmielewski, M.; Cardona, F.; Goti, A.; Brandi, A. Tetrahedron:
Asymmetry 2001, 12, 3163. (c) Pas´niczek, K.; Socha, D.; Jurczak, M.; Frelek,
J.; Suszczyn´ska, A.; Urban´czyk-Lipkowska, Z.; Chmielewski, M. J. Carbohydr.
Chem. 2003, 22, 613. (d) Stecko, S.; Pas´niczek, K.; Jurczak, M.; Urban´czyk-
Lipkowska, Z.; Chmielewski, M. Tetrahedron: Asymmetry 2006, 17, 68. (e)
Stecko, S.; Pas´niczek, K.; Jurczak, M.; Urban´czyk-Lipkowska, Z.; Chmielewski,
M. Tetrahedron: Asymmetry 2007, 18, 1085.
(1) (a) ComprehensiVe Heterocyclic Chemistry II; Katritzky, A. R., Rees,
C. W., Scriven, E.F., Eds.; Pergamon: New York, 1996; Chapter 1.18-1.20.
(b) Ojima, I.; Delaloge, F. Chem. ReV. Soc. 1997, 26, 377. (c) Ojima, I. Acc.
Chem. Res. 1995, 28, 383. (d) Magriotis, P. A. Angew. Chem., Int. Ed. 2001,
40, 4377. (e) Synthesis of ꢀ-Lactam Antibiotics, Chemistry, Biocatalysis and
Process Integration; Bruggink, A., Ed.; Kluwer: Dordrecht, The Netherlands,
2001. (f) Chemistry and Biology of ꢀ-Lactam Antibiotics; Morin, M. B. M.,
Gorman, M.B., Eds.; Academic Press: New York, 1982. (g) The Organic
Chemistry of ꢀ-Lactams; Georg, G.I., Ed.;Wiley-VCH: New York, 1993.
(2) Staudinger, H. Ann. Chem. 1907, 356, 51.
(3) (a) Palomo, C.; Aizpurua, J. M.; Ganboa, I.; Oiarbide, M. Curr. Med.
Chem. 2004, 11, 1837. (b) Deshmukh, A.R.A.S.; Bhwal, B. M.; Krishnaswamy,
D.; Govande, V. V.; Shinkre, B. A.; Jayanti, A. Curr. Med. Chem. 2004, 11,
1889. (c) Alcaide, B.; Almendros, P. Curr. Med. Chem. 2004, 11, 1921. (d)
Alcaide, B.; Almendros, P.; Argoncillo, C. Chem. ReV. 2007, 107, 4437.
(4) Kinugasa, M.; Hashimoto, S. J. Chem. Soc., Chem. Commun. 1972, 466.
(13) (a) Cicchi, S.; Ho¨ld, I.; Brandi, A. J. Org. Chem. 1993, 58, 5274. (b)
Cicchi, S.; Goti, A.; Brandi, A. J. Org. Chem. 1995, 60, 4743.
7402 J. Org. Chem. 2008, 73, 7402–7404
10.1021/jo801212q CCC: $40.75 2008 American Chemical Society
Published on Web 08/08/2008